lenacapavir (Pending FDA Approval)

Brand and Other Names:
  • Print

Dosing & Uses

HIV-1 Infection

Pending FDA approval for treatment of HIV-1 in heavily treatment-experienced people with multi-drug resistant infection

Next:

Pharmacology

Mechanism of Action

Capsid inhibitor; interferes with HIV capsid, a protein shell that protects HIV’s genetic material and enzymes needed for replication

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.